Ultragenyx Reports First Quarter 2019 Financial Results and Corporate Update
Go back to Ultragenyx Reports First Quarter 2019 Financial Results and Corporate Update| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 34.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.67 | 52 Week High | $117.12 | |||
| Open | $34.67 | 52 Week Low | $46.52 | |||
| Day High | $34.67 | P/E | N/A | |||
| Day Low | $34.67 | EPS | $-1.97 | |||
| Volume | 7,808 | |||||
